Toxic Interactions Of Romiplostim And Rituximab In Normal And Thrombocytopenic Rats
Journal Title: Journal of Applied Veterinary Sciences - Year 2020, Vol 5, Issue 1
Abstract
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immunologic destruction of normal platelets and insufficient production of platelets mediated by autoantibodies. And there are different treatment options for management of thrombocytopenia according to each case. Because of the progression of the disease and its multiple pathophysiological pathways a combination of treatments used for management of ITP would be a point of interest. Co-administration of therapies may be useful in patients who are refractory to monotherapies and may result in a booster response because they target multiple mechanisms. Romiplostim is a potent drug used for the management of acute ITP and can be administered with other treatment options for ITP. The combination of Rituximab and Romiplostim may inhibit platelet destruction and at the same time increase platelet production. This combination can lead to a strong and a massive increase in platelet counts. In preclinical studies of Romiplostim safety margins could not be reliably estimated. Although some post marketing surveillance studies provided some information about the safety profile of this drug. More information is needed to evaluate drug interactions between Romiplostim and Rituximab.The goal of this study is to investigate the safety of co-treatment of Romiplostim with Rituximab as compared to each of these drugs in normal rats and thrombocytopenic rats. The measured safety parameters were evaluated for liver and kidney functions in normal and diseased groups of rats.The safety of this regimen should be taken in consideration, so that a balance between the harmful effects and beneficial response could be attained. Future studies are necessary to investigate the safety and efficacy balance of Romiplostim and Rituximab alone or in combination with each other for management of thrombocytopenia.
Authors and Affiliations
Saeed H. , Sayed H. M. , Ramadan A. , Nahla S. Kotb
Keywords
Related Articles
- EP ID EP679159
- DOI https://dx.doi.org/10.21608/javs.2019.20470.1000
- Views 211
- Downloads 1
Preparation Of Inactivated Infectious Bursal Disease Virus Vaccine From Classical Strain And Local Variant Isolates
This study was conducted to assess an inactivated vaccine prepared from local field isolates of Infectious Bursal Disease (IBD) "local variant and virulent isolates" and a classical strain "bursa vacc" to improve the ful...
Factors Affecting on Production of Clostridium novyi type (B) Alpha Toxin
Clostridium novyi type B is an anaerobic bacterium that causes black disease (infectious necrotic hepatitis). The alpha toxin is considered as a major virulence factor. The disease has been controlled using toxoid vaccin...
Ultrasonography, Histopathological Udder Alterations And Bacteriological Investigations For Diagnosis Of Mastitic Goats
The purpose of this study was to evaluate the ultrasound and histopathological findings in comparison with the bacteriological examination to help in prognosis decision for udder alteration occurred by different cause an...
Ginseng Extract can alleviate The Induced-renal Toxicity of Titanium Dioxide Nanoparticles in a Rat Model
Titanium dioxide nanoparticles (TiO2-NPs) are widely utilized in cosmetics, food, and paintings. Although TiO2-NPs may cause toxicity through a variety of routes, oxidative stress is by far the most common. Ginseng is em...
Comparison Between Electroacupuncture, Detomidine Plus Electroacupuncture And Detomidine Alone For Laparoscopic Surgery In Goats
This study aimed to validate the effectiveness of electroacupuncture (EA), detomidine plus electroacupuncture and detomidine alone for laparoscopy in goats in terms of physiological variables, vital parameters, CBC and p...